Evidence map›Paper›PMID 26139129›Full record

ReviewNanomedicine (London, England)2015

Nanotechnology for enrichment and detection of circulating tumor cells.

Saheel Bhana, Yongmei Wang, Xiaohua Huang

Abstract readReview
In one paragraph

Review in Nanomedicine (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Cell-Free DNA-Based Theranostics for Inflammatory Disorders.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Saheel BhanaDepartment of Chemistry, The University of Memphis, Memphis, TN 38152, USA.
Yongmei WangDepartment of Chemistry, The University of Memphis, Memphis, TN 38152, USA.
Xiaohua HuangDepartment of Chemistry, The University of Memphis, Memphis, TN 38152, USA.

Funding

Hybrid nanoparticles for capture and detection of circulating tumor cellsR15CA195509 · NCI · UNIVERSITY OF MEMPHIS · PI HUANG, XIAOHUA · 2015 to 2015
$405k
NCI NIH HHS R15 CA195509
6 · The paper itself

Abstract

Circulating tumor cells (CTCs) are a hallmark of invasive behavior of cancer, responsible for the development of metastasis. Their detection and analysis have significant impacts in cancer biology and clinical practice. However, CTCs are rare events and contain heterogeneous subpopulations, requiring highly sensitive and specific techniques to identify and capture CTCs with high efficiency. Nanotechnology shows strong promises for CTC enrichment and detection owning to the unique structural and functional properties of nanoscale materials. In this review, we discuss the CTC enrichment and detection technologies based on a variety of functional nanosystems and nanostructured substrates, with the goal to highlight the role of nanotechnology in the advancement of basic and clinical CTC research.

Indexed as

AnimalsBatch Cell Culture TechniquesCell SeparationCell TrackingHumansImmunomagnetic SeparationMagnetic Resonance ImagingMagnetite NanoparticlesNeoplastic Cells, CirculatingMagnetite Nanoparticlescirculating tumor cellsdetectionenrichmentfunctional nanoparticlesmicrofluidicsnanostructured substratesnanotechnology

Identifiers

PMID26139129
PMCPMC4889019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.